
|Articles|December 10, 2011
Video blog: HER2-targeted agents
Author(s)Debu Tripathy
Advertisement
Dr. Debu Tripathy explains the HER2 pathway's involvement in breast cancer and how new investigational drugs, including pertuzumab and TDM1, as well as combinations of new and approved drugs are targeting this pathway.
Advertisement
Advertisement
Advertisement
Trending on CURE
1
Given Months to Live, She’s Now a Five-Year Glioblastoma Survivor
2
Uveal Melanoma Guide: An Overview From Diagnosis to Treatment and Beyond
3
My Three-Time Cancer Journey
4
Tecvayli With Darzalex Could Be ‘Truly Transformative’ in Multiple Myeloma
5




